Quanterix Co. (NASDAQ:QTRX) Stock Position Raised by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its stake in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 23.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 270,054 shares of the company's stock after buying an additional 52,097 shares during the period. JPMorgan Chase & Co. owned about 0.70% of Quanterix worth $2,871,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the company. KLP Kapitalforvaltning AS purchased a new position in shares of Quanterix during the 4th quarter worth approximately $66,000. Peapack Gladstone Financial Corp purchased a new position in shares of Quanterix during the 3rd quarter worth about $131,000. Levin Capital Strategies L.P. purchased a new position in Quanterix during the fourth quarter worth approximately $159,000. Tallon Kerry Patrick purchased a new stake in Quanterix during the fourth quarter valued at about $169,000. Finally, Moors & Cabot Inc. increased its position in Quanterix by 107.5% during the 4th quarter. Moors & Cabot Inc. now owns 30,873 shares of the company's stock worth $328,000 after purchasing an additional 15,992 shares in the last quarter. Hedge funds and other institutional investors own 86.48% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Canaccord Genuity Group decreased their target price on Quanterix from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, March 18th. Scotiabank reissued an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th.

Quanterix Stock Performance

Shares of Quanterix stock traded up $0.28 during trading on Friday, hitting $5.88. 618,045 shares of the stock were exchanged, compared to its average volume of 545,398. The stock's fifty day moving average is $6.54 and its 200 day moving average is $9.55. The stock has a market cap of $228.08 million, a PE ratio of -5.55 and a beta of 1.35. Quanterix Co. has a 12 month low of $4.67 and a 12 month high of $19.18.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings data on Monday, March 17th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The company had revenue of $35.16 million for the quarter, compared to the consensus estimate of $34.93 million. Sell-side analysts anticipate that Quanterix Co. will post -0.98 EPS for the current fiscal year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.